Solid Biosciences Inc. SLDB Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc.ORKA

-$125K-495%

Rumble, Inc.RUM

-$337.78K-40.4%

Mission Produce, Inc.AVO

-$2.8M-3.7%

The Baldwin Insurance Group, Inc.BWIN

-$4.74M-16.2%

NextNavNN

$77K-63.7%

Target HospitalityTH

-$2.3M-33.9%

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$872.26M+135%

Enterprise value$595.83M+223%

P/S107.8×-9.9×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s short- and long-term operating lease liabilities?: Solid Biosciences Inc. (SLDB) reported short- and long-term operating lease liabilities of -$496K in Q1 2026.
How has Solid Biosciences Inc.'s short- and long-term operating lease liabilities changed year-over-year?: Solid Biosciences Inc.'s short- and long-term operating lease liabilities decreased by 19.2% year-over-year, from -$416K to -$496K.